United Therapeutics SG&A Expenses 2010-2024 | UTHR
- United Therapeutics annual sg&a expenses for 2023 were $0.477B, a 1.04% decline from 2022.
- United Therapeutics annual sg&a expenses for 2022 were $0.482B, a 3.23% increase from 2021.
- United Therapeutics annual sg&a expenses for 2021 were $0.467B, a 10.17% increase from 2020.